High-level nuclear NF-kappa B and Oct-2 is a common feature of cultured Hodgkin/Reed-Sternberg cells

被引:256
作者
Bargou, RC [1 ]
Leng, C [1 ]
Krappmann, D [1 ]
Emmerich, F [1 ]
Mapara, MY [1 ]
Bommert, K [1 ]
Royer, HD [1 ]
Scheidereit, C [1 ]
Dorken, B [1 ]
机构
[1] FREE UNIV BERLIN, UNIV MED CTR RUDOLF VIRCHOW, ROBERT ROSSLE KLIN, DEPT INTERNAL MED, BERLIN, GERMANY
关键词
D O I
10.1182/blood.V87.10.4340.bloodjournal87104340
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
There is a considerable lack of understanding about the common molecular defects that form the basis for the occurrence of Hodgkin's lymphoma. Despite a number of molecular tools used thus far in immunophenotypic and karyotypic studies, it has not been possible to establish a single common trait among various Hodgkin (H)-cell lines or primary tumor cells that would allow classification into a particular hematopoietic lineage. With this study, we demonstrate that a characteristic expression pattern of transcription factors provides a unifying principle. Seven different cell lines derived from patients with Hodgkin's disease (HD), as well as primary H/Reed-Sternberg (RS) cells isolated from the pericardial fluid of a patient with HD, were compared with a number of hematopoietic and nonhematopoietic cell lines for the expression of Oct-2, a tissue-specific transcription factor normally restricted to B cells, and nuclear factor KB (NF-KB), an inducible transcription factor. Regardless of the heterogeneous phenotypes and genotypes of the H cell lines, which varied inconsistently between B-cell-, T-cell-, or monocyte-like properties, all H cells tested displayed expression of Oct-2 protein at levels comparable to those seen in B cells. Furthermore, all cell lines showed an abundant constitutive nuclear NF-kappa B activity. Interestingly, anaplastic large-cell lymphoma (ALCL) cell lines, which have many features in common with H/RS cells, were devoid of constitutive nuclear NF-kappa B activity. Unlike the constitutive NF-kappa B activity known for B cells, which mainly consists of the p50 and c-Rel or RelB subunits, we demonstrate by antibody supershifting experiments that H cells contain constitutive nuclear p50 and p65, the dimeric NF-kappa B normally observed only for limited time intervals after stimulation with diverse inducers. Additionally, some H-cell lines also displayed nuclear c-Rel activity, whereas RelB or p52 were not detected as part of the constitutive activity. The expression pattern of Oct-2 and NF-kappa B appears to be a unifying and characteristic property of H cells and might explain the deregulated expression of various cytokines leading to the clinical and pathologic manifestations of HD. (C) 1996 by The American Society of Hematology.
引用
收藏
页码:4340 / 4347
页数:8
相关论文
共 34 条
  • [1] BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141
  • [2] I-KAPPA-B - A SPECIFIC INHIBITOR OF THE NF-KAPPA-B TRANSCRIPTION FACTOR
    BAEUERLE, PA
    BALTIMORE, D
    [J]. SCIENCE, 1988, 242 (4878) : 540 - 546
  • [3] CHARACTERIZATION OF A NOVEL HODGKIN CELL-LINE, HD-MYZ, WITH MYELOMONOCYTIC FEATURES MIMICKING HODGKINS-DISEASE IN SEVERE COMBINED IMMUNODEFICIENT MICE
    BARGOU, RC
    MAPARA, MY
    ZUGCK, C
    DANIEL, PT
    PAWLITA, M
    DOHNER, H
    DORKEN, B
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (05) : 1257 - 1268
  • [4] THE B-CELL-SPECIFIC OCT-2 PROTEIN CONTAINS POU BOX-TYPE AND HOMEO BOX-TYPE DOMAINS
    CLERC, RG
    CORCORAN, LM
    LEBOWITZ, JH
    BALTIMORE, D
    SHARP, PA
    [J]. GENES & DEVELOPMENT, 1988, 2 (12A) : 1570 - 1581
  • [5] OCTAMER-BINDING PROTEINS IN DIVERSE HEMATOPOIETIC-CELLS
    COCKERILL, PN
    KLINKEN, SP
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1990, 10 (03) : 1293 - 1296
  • [6] DIEHL V, 1990, SEMIN ONCOL, V17, P660
  • [7] ACCURATE TRANSCRIPTION INITIATION BY RNA POLYMERASE-II IN A SOLUBLE EXTRACT FROM ISOLATED MAMMALIAN NUCLEI
    DIGNAM, JD
    LEBOVITZ, RM
    ROEDER, RG
    [J]. NUCLEIC ACIDS RESEARCH, 1983, 11 (05) : 1475 - 1489
  • [8] GRILLI M, 1993, INT REV CYTOL, V1, P1
  • [9] GRUMONT RJ, 1993, CELL GROWTH DIFFER, V4, P731
  • [10] GRUSS HJ, 1992, CANCER RES, V52, P3353